These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

570 related articles for article (PubMed ID: 26844759)

  • 1. The therapeutic potential of cell identity reprogramming for the treatment of aging-related neurodegenerative disorders.
    Smith DK; He M; Zhang CL; Zheng JC
    Prog Neurobiol; 2017 Oct; 157():212-229. PubMed ID: 26844759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induced pluripotency and direct reprogramming: a new window for treatment of neurodegenerative diseases.
    Li R; Bai Y; Liu T; Wang X; Wu Q
    Protein Cell; 2013 Jun; 4(6):415-24. PubMed ID: 23686735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reverse engineering human neurodegenerative disease using pluripotent stem cell technology.
    Liu Y; Deng W
    Brain Res; 2016 May; 1638(Pt A):30-41. PubMed ID: 26423934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatic cell reprogramming as a tool for neurodegenerative diseases.
    Ebrahimi A; Keske E; Mehdipour A; Ebrahimi-Kalan A; Ghorbani M
    Biomed Pharmacother; 2019 Apr; 112():108663. PubMed ID: 30970509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reprogramming of somatic cells to induced neural stem cells.
    Shahbazi E; Mirakhori F; Ezzatizadeh V; Baharvand H
    Methods; 2018 Jan; 133():21-28. PubMed ID: 28939501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential application of induced pluripotent stem cells in cell replacement therapy for Parkinson's disease.
    Chen LW; Kuang F; Wei LC; Ding YX; Yung KK; Chan YS
    CNS Neurol Disord Drug Targets; 2011 Jun; 10(4):449-58. PubMed ID: 21495962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induced pluripotent stem cells and their use in cardiac and neural regenerative medicine.
    Skalova S; Svadlakova T; Shaikh Qureshi WM; Dev K; Mokry J
    Int J Mol Sci; 2015 Feb; 16(2):4043-67. PubMed ID: 25689424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disease Modeling of Neurodegenerative Disorders Using Direct Neural Reprogramming.
    Legault EM; Bouquety J; Drouin-Ouellet J
    Cell Reprogram; 2022 Oct; 24(5):228-251. PubMed ID: 35749150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Progress in induced pluripotent stem cell research for age-related neurodegenerative diseases].
    Ito D; Yagi T; Suzuki N
    Brain Nerve; 2013 Mar; 65(3):283-8. PubMed ID: 23475520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell reprogramming: Therapeutic potential and the promise of rejuvenation for the aging brain.
    López-León M; Outeiro TF; Goya RG
    Ageing Res Rev; 2017 Nov; 40():168-181. PubMed ID: 28903069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progress and Challenges of Cell Replacement Therapy for Neurodegenerative Diseases Based on Direct Neural Reprogramming.
    Chen Y; Pu J; Zhang B
    Hum Gene Ther; 2016 Dec; 27(12):962-970. PubMed ID: 27589383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Introduction for Stem Cell-Based Therapy for Neurodegenerative Diseases.
    Han F; Lu P
    Adv Exp Med Biol; 2020; 1266():1-8. PubMed ID: 33105491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in reprogramming-based study of neurologic disorders.
    Nityanandam A; Baldwin KK
    Stem Cells Dev; 2015 Jun; 24(11):1265-83. PubMed ID: 25749371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation of Neural Stem Cells and Progenitors: Neuronal Production and Grafting Applications.
    Zholudeva LV; Jin Y; Qiang L; Lane MA; Fischer I
    Methods Mol Biol; 2021; 2311():73-108. PubMed ID: 34033079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Remodeling neurodegeneration: somatic cell reprogramming-based models of adult neurological disorders.
    Qiang L; Fujita R; Abeliovich A
    Neuron; 2013 Jun; 78(6):957-69. PubMed ID: 23791192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemically Induced Reprogramming of Somatic Cells to Pluripotent Stem Cells and Neural Cells.
    Biswas D; Jiang P
    Int J Mol Sci; 2016 Feb; 17(2):226. PubMed ID: 26861316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human-induced pluripotent stem cells: potential for neurodegenerative diseases.
    Ross CA; Akimov SS
    Hum Mol Genet; 2014 Sep; 23(R1):R17-26. PubMed ID: 24824217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neural stem cell-based treatment for neurodegenerative diseases.
    Kim SU; Lee HJ; Kim YB
    Neuropathology; 2013 Oct; 33(5):491-504. PubMed ID: 23384285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induced Pluripotency: A Powerful Tool for In Vitro Modeling.
    Zahumenska R; Nosal V; Smolar M; Okajcekova T; Skovierova H; Strnadel J; Halasova E
    Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33255453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress in the reprogramming of somatic cells.
    Ma T; Xie M; Laurent T; Ding S
    Circ Res; 2013 Feb; 112(3):562-74. PubMed ID: 23371904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.